The authors would like to make the following corrections about the published paper [1]. The changes are as follows:
Missing Citation
In the original publication, refs. [2,3] was not cited. The citation has now been inserted in 4. The Skin Endocannabinoid System and the Use of Cannabinoids as a Potential Treatment for Skin Inflammatory Diseases, 4.1. The Skin Endocannabinoid System, Table 2 caption. Newly add references as [47,48] in the original paper, the order of some reference citation has been adjusted correspondingly.
“Table 2. The different classes of cannabinoids located in the skin, and some examples [15,37,47,48].”
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Martins A.M., Gomes A.L., Vilas Boas I., Marto J., Ribeiro H.M. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals. 2022;15:210. doi: 10.3390/ph15020210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Muller C., Morales P., Reggio P.H. Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci. 2019;11:487. doi: 10.3389/fnmol.2018.00487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mnekin L., Ripoll L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics. 2021;8:85 [Google Scholar]